Neha Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-07-2024
- Paid Up Capital ₹ 0.10 M
as on 24-07-2024
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 26.95%
(FY 2023)
- Profit 24.91%
(FY 2023)
- Ebitda 148.43%
(FY 2023)
- Net Worth 4.78%
(FY 2023)
- Total Assets 2.23%
(FY 2023)
About Neha Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kirit Shah, Kirit Gandhi, Prashant Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1988PTC048523
- Company No.
048523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Neha Pharma Pvt Ltd offer?
Neha Pharma Pvt Ltd offers a wide range of products and services, including Animal Medicines & Health Care, Anthelmintics, Antibiotic Tablets & Capsules, Azithromycin Tablets, Antihistamines, Phenylephrine Hcl Tablet, Chemical Compound, Flavours & Aromatics, Food Additive, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Neha Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kirit Shah  | Managing Director | 17-Aug-1988 | Current |
| Kirit Gandhi | Managing Director | 17-Aug-1988 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratik Gandhi | Whole-Time Director | 01-Sep-2007 | Current |
| Prashant Shah | Director | 01-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Neha Pharma.
Neha Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 26.95% increase. The company also saw a substantial improvement in profitability, with a 24.91% increase in profit. The company's net worth moved up by a moderate rise of 4.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neha Pharma?
In 2023, Neha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neha Pharma?
Unlock and access historical data on people associated with Neha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
